Accessibility Menu
Vycor Medical Stock Quote

Vycor Medical (OTC: VYCO)

$0.18
(16.7%)
+0.03
Price as of November 3, 2025, 2:04 p.m. ET

KEY DATA POINTS

Current Price
$0.18
Daily Change
(16.7%) +$0.03
Day's Range
$0.10 - $0.18
Previous Close
$0.18
Open
$0.10
Beta
0.44
Volume
13,000
Average Volume
2,377
Market Cap
5.8M
Market Cap / Employee
$0.17M
52wk Range
$0.04 - $0.50
Revenue
-
Gross Margin
0.82%
Dividend Yield
N/A
EPS
-$0.01
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Vycor Medical Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
VYCO+124.65%-11.62%-2.43%-100%
S&P+18.54%+92.9%+14.04%+749%

Vycor Medical Company Info

Vycor Medical, Inc. engages in the provision of innovative surgical and therapeutic solutions to the medical community. It operates through the Vycor Medical and NovaVision segments. The Vycor Medical segment focuses on devices for neurosurgery. The NovaVision segment offers neuro stimulation therapies and diagnostic devices for the treatment and screening of vision field loss. The company was founded by Heather N. Vinas and Heather N. Jensen on June 17, 2005 and is headquartered in Boca Raton, FL.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$0.50M22.2%
Gross Profit$0.40M12.4%
Gross Margin80.67%-7.0%
Market Cap$4.41M50.3%
Market Cap / Employee$0.63M0.0%
Employees7-12.5%
Net Income$0.03M357.4%
EBITDA$0.07M107.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$0.10M-16.4%
Accounts Receivable$0.20M-19.8%
Inventory0.2-28.5%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.16M-24.6%
Short Term Debt$0.85M0.4%

Ratios

Q2 2025YOY Change
Return On Assets-8.45%10.7%
Return On Invested Capital16.69%-9.3%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$0.04M0.0%
Operating Free Cash Flow$0.05M-45.8%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book-0.72-0.63-0.59-1.1335.90%
Price to Sales1.781.181.202.8733.15%
Price to Tangible Book Value-0.72-0.63-0.59-1.1335.91%
Enterprise Value to EBITDA-179.8177.94904.8690.97-25.21%
Total Debt$1.08M$1.06M$1.03M$1.01M-4.74%

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.